Remyelination protects axons from demyelination-associated axon degeneration.
暂无分享,去创建一个
[1] K. Irvine,et al. A different regional response by mouse oligodendrocyte progenitor cells (OPCs) to high‐dose X‐irradiation has consequences for repopulating OPC‐depleted normal tissue , 2007, The European journal of neuroscience.
[2] W. F. Blakemore,et al. Age increases axon loss associated with primary demyelination in cuprizone-induced demyelination in C57BL/6 mice , 2006, Journal of Neuroimmunology.
[3] Blakemore Wf,et al. Age increases axon loss associated with primary demyelination in cuprizone-induced demyelination in C57BL/6 mice. , 2006 .
[4] T. Kilpatrick,et al. Suppressor of cytokine signaling 3 limits protection of leukemia inhibitory factor receptor signaling against central demyelination , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[5] W. Blakemore,et al. Repopulation of oligodendrocyte progenitor cell‐depleted tissue in a model of chronic demyelination , 2005, Neuropathology and applied neurobiology.
[6] G. Comi,et al. Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism , 2005, Nature.
[7] S. Skaper,et al. Excitatory amino acid induced oligodendrocyte cell death in vitro: receptor‐dependent and ‐independent mechanisms , 2004, Journal of neurochemistry.
[8] E. Brand-Schieber,et al. Calcium channel blockers ameliorate disease in a mouse model of multiple sclerosis , 2004, Experimental Neurology.
[9] I. Duncan,et al. Oligodendroglial modulation of fast axonal transport in a mouse model of hereditary spastic paraplegia , 2004, The Journal of cell biology.
[10] H. Keirstead,et al. Remyelination, axonal sparing, and locomotor recovery following transplantation of glial-committed progenitor cells into the MHV model of multiple sclerosis , 2004, Experimental Neurology.
[11] W. Blakemore,et al. Suppression of remyelination in the CNS by X-irradiation , 1978, Acta Neuropathologica.
[12] T. Ben-Hur,et al. Intraventricular transplantation of neural precursor cell spheres attenuates acute experimental allergic encephalomyelitis , 2003, Molecular and Cellular Neuroscience.
[13] D. Offen,et al. Axonal damage is reduced following glatiramer acetate treatment in C57/bl mice with chronic-induced experimental autoimmune encephalomyelitis , 2003, Neuroscience Research.
[14] T. Kawakami,et al. Glutamate and Amyloid β-Protein Rapidly Inhibit Fast Axonal Transport in Cultured Rat Hippocampal Neurons by Different Mechanisms , 2003, The Journal of Neuroscience.
[15] Scott T. Brady,et al. Neuropathogenic Forms of Huntingtin and Androgen Receptor Inhibit Fast Axonal Transport , 2003, Neuron.
[16] Richard G. Brusch,et al. Disruption of Axonal Transport by Loss of Huntingtin or Expression of Pathogenic PolyQ Proteins in Drosophila , 2003, Neuron.
[17] W. Blakemore,et al. Dysfunctional oligodendrocyte progenitor cell (OPC) populations may inhibit repopulation of OPC depleted tissue , 2003, Journal of neuroscience research.
[18] Robert Layfield,et al. Oligodendrocytes Promote Neuronal Survival and Axonal Length by Distinct Intracellular Mechanisms: A Novel Role for Oligodendrocyte-Derived Glial Cell Line-Derived Neurotrophic Factor , 2003, The Journal of Neuroscience.
[19] K. Nave,et al. Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination , 2003, Nature Genetics.
[20] T. Grune,et al. Impairment of protein homeostasis and decline of proteasome activity in microglial cells from adult Wistar rats , 2003, Journal of neuroscience research.
[21] A. Crosby,et al. Is the transportation highway the right road for hereditary spastic paraplegia? , 2002, American journal of human genetics.
[22] Melitta Schachner,et al. Neural stem cells display an inherent mechanism for rescuing dysfunctional neurons , 2002, Nature Biotechnology.
[23] Wolfgang Brück,et al. Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time. , 2002, Brain : a journal of neurology.
[24] W. Blakemore,et al. New insights into remyelination failure in multiple sclerosis: implications for glial cell transplantation , 2002, Multiple sclerosis.
[25] T. Montine,et al. In Vivo Assessment of Lipid Peroxidation Products Associated with Age-Related Neurodegenerative Diseases , 2002, Experimental Neurology.
[26] H. Lassmann,et al. CNTF is a major protective factor in demyelinating CNS disease: A neurotrophic cytokine as modulator in neuroinflammation , 2002, Nature Medicine.
[27] A. Crang,et al. Modelling large areas of demyelination in the rat reveals the potential and possible limitations of transplanted glial cells for remyelination in the CNS , 2002, Glia.
[28] Chao Zhao,et al. The Age-Related Decrease in CNS Remyelination Efficiency Is Attributable to an Impairment of Both Oligodendrocyte Progenitor Recruitment and Differentiation , 2002, The Journal of Neuroscience.
[29] S. Waxman. Sodium channels as molecular targets in multiple sclerosis. , 2002, Journal of rehabilitation research and development.
[30] D. Westaway,et al. Phenotypic and functional changes in glial cells as a function of age , 2002, Neurobiology of Aging.
[31] A Compston,et al. A role for oligodendrocyte‐derived IGF‐1 in trophic support of cortical neurons , 2001, Glia.
[32] Scott T. Brady,et al. Changes in Microtubule Stability and Density in Myelin-Deficient Shiverer Mouse CNS Axons , 2001, The Journal of Neuroscience.
[33] R. Franklin,et al. Depletion of endogenous oligodendrocyte progenitors rather than increased availability of survival factors is a likely explanation for enhanced survival of transplanted oligodendrocyte progenitors in X‐irradiated compared to normal CNS , 2001, Neuropathology and applied neurobiology.
[34] R. Franklin,et al. Delayed Changes in Growth Factor Gene Expression during Slow Remyelination in the CNS of Aged Rats , 2000, Molecular and Cellular Neuroscience.
[35] P. Ye,et al. Insulin-Like Growth Factor-1 Inhibits Mature Oligodendrocyte Apoptosis during Primary Demyelination , 2000, The Journal of Neuroscience.
[36] H. Lassmann,et al. Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. , 2000, The American journal of pathology.
[37] W. Brück,et al. Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. , 2000, Brain : a journal of neurology.
[38] D. Pitt,et al. Glutamate excitotoxicity in a model of multiple sclerosis , 2000, Nature Medicine.
[39] R. Franklin,et al. Remyelination occurs as extensively but more slowly in old rats compared to young rats following gliotoxin‐induced CNS demyelination , 1999, Glia.
[40] C. Svendsen,et al. Mouse epidermal growth factor-responsive neural precursor cells increase the survival and functional capacity of embryonic rat dopamine neurons in vitro. , 1999, Neuroreport.
[41] K. Unsicker,et al. GDNF family members and their receptors: Expression and functions in two oligodendroglial cell lines representing distinct stages of oligodendroglial development , 1999, Glia.
[42] K. Nave,et al. Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. , 1998, Science.
[43] T. Morgan,et al. Age-Related Activation of Microglia and Astrocytes: In Vitro Studies Show Persistent Phenotypes of Aging, Increased Proliferation, and Resistance to Down-Regulation , 1998, Neurobiology of Aging.
[44] G. Wolswijk. Chronic Stage Multiple Sclerosis Lesions Contain a Relatively Quiescent Population of Oligodendrocyte Precursor Cells , 1998, The Journal of Neuroscience.
[45] ichard,et al. AXONAL TRANSECTION IN THE LESIONS OF MULTIPLE SCLEROSIS , 1998 .
[46] K. Smith,et al. Nitric oxide donors reversibly block axonal conduction: demyelinated axons are especially susceptible. , 1997, Brain : a journal of neurology.
[47] V. Perry,et al. Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke , 1997, Neuropathology and applied neurobiology.
[48] H. Webster,et al. Growth factors and myelin regeneration in multiple sclerosis , 1997, Multiple sclerosis.
[49] S. Sakoda,et al. Nitric oxide via an inducible isoform of nitric oxide synthase is a possible factor to eliminate inflammatory cells from the central nervous system of mice with experimental allergic encephalomyelitis , 1997, Journal of Neuroimmunology.
[50] J. Merrill,et al. The role of nitric oxide in multiple sclerosis , 1997, Journal of Molecular Medicine.
[51] V. Perry,et al. Axonal damage in acute multiple sclerosis lesions. , 1997, Brain : a journal of neurology.
[52] J. Fawcett,et al. Migration of oligodendrocyte precursors on astrocytes and meningeal cells. , 1995, Developmental biology.
[53] S. Brady,et al. Modulation of the axonal microtubule cytoskeleton by myelinating Schwann cells , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[54] A. Campagnoni,et al. Murine oligodendroglial cells express nerve growth factor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[55] D. Giulian,et al. Brain glia release factors with opposing actions upon neuronal survival , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[56] Scott T. Brady,et al. Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells , 1992, Cell.
[57] J. Winn,et al. Brain , 1878, The Lancet.
[58] W. Carlton,et al. Monoamine oxidase inhibition and the activity of other oxidative enzymes in the brains of mice fed cuprizone. , 1971, Toxicology and applied pharmacology.
[59] I. Pattison,et al. Clinical and histological observations on cuprizone toxicity and scrapie in mice. , 1971, Research in veterinary science.